(917) 310-3371
Lp(a)
Lp(a) is largely inherited. A once-in-adulthood measurement can identify a risk enhancer that is not visible in a standard lipid panel.
Cholesterol care | New York
Advanced lipid testing evaluation in NYC and Long Island
A decision-focused review of which measurements can add useful information, how results affect care, and when broader cardiovascular evaluation is needed.
Start with evaluation, not a product assumption
The care team must confirm clinical fit, current records, monitoring, access, and the correct site before treatment moves forward.
Direct answer
Advanced lipid testing is not one universal panel. Current 2026 AHA and ACC guidance recommends measuring lipoprotein(a), or Lp(a), at least once in adulthood. It also supports selective use of apolipoprotein B, or ApoB, when that result can improve a risk or treatment decision. Standard LDL, HDL, triglycerides, and non-HDL cholesterol remain central. A clinician should order only tests that have a clear purpose.
Current product and service status
Nao Medical can coordinate an evaluation and testing. The care team must confirm the exact test, laboratory network, patient cost, turnaround time, and interpretation pathway for each patient.
Measurements that may answer different questions
The useful test depends on the decision in front of the patient and clinician.
ApoB
ApoB estimates the number of atherogenic lipoprotein particles and can add context in selected patients, including some people with high triglycerides, diabetes, or discordant results.
Non-HDL cholesterol
Non-HDL cholesterol is calculated from the standard panel and captures cholesterol carried by atherogenic particles beyond LDL alone.
When more information may help
Testing should resolve uncertainty or change management, not simply make a report longer.
Unexpected or persistent results
Repeat standard testing and a review of fasting status, adherence, medicines, and other conditions may come before specialized tests.
Family or premature disease
Strong family history, very high LDL, or early cardiovascular disease can support a more detailed inherited-risk assessment.
Risk-treatment mismatch
Additional measurements may help when calculated risk, LDL, triglycerides, diabetes, kidney disease, or observed disease do not tell a consistent story.
What results do and do not mean
A number needs clinical context before it becomes a treatment plan.
One result is not a diagnosis
Interpret the result with age, history, blood pressure, smoking, diabetes, kidney health, and current treatment.
A normal result does not erase risk
Other risk factors and established cardiovascular disease still matter.
An abnormal result does not select a brand
Medication choice depends on the full risk picture, LDL goal, evidence, safety, response, preference, and coverage.
How the evaluation moves forward
The sequence protects safety and keeps a product request from bypassing diagnosis, records, monitoring, access, or referral needs.
Bring the record
Bring recent lipid results, a current medication and supplement list, prior reactions, relevant diagnoses, and family history when available.
Review risk and prior treatment
The clinician reviews the reason for treatment, prior response, safety considerations, adherence barriers, and the role of lifestyle support.
Choose the next step
The plan may include repeat or additional testing, a medication change, teaching, prior-authorization work, specialist coordination, or continued monitoring.
Confirm follow-up
The care team confirms how results and symptoms will be reviewed. Product supply or administration is arranged only after operational capability is verified.
Evaluation locations across New York
Choose a nearby Nao Medical clinic as a starting point for evaluation or care coordination.
Capability boundary: these location cards do not establish that a medicine, device, laboratory test, injection, or specialty workflow is available at every site. Confirm the exact service before travel.
Bronx
174th Street
932 E 174th St, Bronx, NY 10460
A place to begin evaluation and care coordination near West Farms, Crotona Park East, and nearby Bronx neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A place to begin evaluation and care coordination near Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Bronx
Bartow Mall
2063A Bartow Ave, Bronx, NY 10475
A place to begin evaluation and care coordination near Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Brooklyn
Crown Heights
341 Eastern Pkwy, Brooklyn, NY 11216
A place to begin evaluation and care coordination near Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
A place to begin evaluation and care coordination near Hicksville, Plainview, Bethpage, and nearby Nassau County communities. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Jackson Heights
80-10 Northern Blvd, Jackson Heights, NY 11372
A place to begin evaluation and care coordination near Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Jamaica
90-18 Sutphin Blvd, Jamaica, NY 11435
A place to begin evaluation and care coordination near Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Long Island City
30-07 36th Ave, Astoria, NY 11106
A place to begin evaluation and care coordination near Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Long Island
Mineola
135 Mineola Blvd, Mineola, NY 11501
A place to begin evaluation and care coordination near Mineola, Garden City, Westbury, and nearby Nassau County communities. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
A place to begin evaluation and care coordination near StuyTown, the East Village, Gramercy, and nearby Manhattan neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Brooklyn
Williamsburg
308 Graham Ave, Brooklyn, NY 11211
A place to begin evaluation and care coordination near Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Related care and next steps
Compare focused options, prepare for an evaluation, and connect medication questions with broader care.
Heart health and cholesterol care
Explore broader cardiovascular prevention and cholesterol care at Nao Medical.
Familial hypercholesterolemia evaluation
Review inherited very high LDL and family screening separately.
Statin intolerance evaluation
Clarify treatment history when side effects limit the plan.
Repatha evaluation
Review a specific medicine only when a medicine-specific question exists.
Leqvio evaluation
Review a clinician-administered option when a medicine-specific question becomes relevant.
Frequently asked questions
Answers reflect current official sources and Nao Medical's limited evaluation and coordination scope.
It is a decision-focused use of measurements beyond, or derived from, a standard lipid panel. Examples include Lp(a), ApoB, and non-HDL cholesterol.
The 2026 AHA and ACC guideline recommends measuring Lp(a) at least once in adulthood because it can identify inherited risk.
ApoB is a protein found on atherogenic lipoprotein particles. Its level can help estimate particle burden in selected clinical situations.
It depends on the tests and clinical question. Ask the ordering clinician or laboratory for instructions instead of assuming.
No. Lp(a) is one risk factor. The plan depends on overall cardiovascular risk, LDL and other results, existing disease, evidence, and available treatments.
Availability is not guaranteed. The care team must confirm the exact test, laboratory pathway, and location before collection.
Frequency depends on the measurement and the clinical purpose. Lp(a) is largely genetic and often does not need frequent repetition; standard lipids are monitored according to treatment and risk.
Official sources
These sources support product identity, approval, current labeling, availability, and clinical boundaries. They do not prove Nao Medical site capability or health-plan coverage.
2026 guideline on the management of dyslipidemia
Current risk assessment, LDL-lowering treatment, Lp(a), ApoB, and monitoring guidance.
Open official sourceTop things to know: 2026 dyslipidemia guideline
Patient-selection principles and the roles of Lp(a), ApoB, and nonstatin therapies.
Open official sourceSource and label check completed August 1, 2026. Named clinical and operations review is still pending.
Connect the evaluation to specific treatment pathways
Diagnosis and long-term care stay anchored in a full condition evaluation. The focused medication, testing, and service information below helps patients compare next steps without replacing that evaluation.
Lipid optimization clinic
Use test results in a broader risk and treatment discussion.
Statin intolerance evaluation
Document prior products, doses, symptoms, and retrial history before choosing alternatives.
Familial hypercholesterolemia
Review inherited patterns and family screening when LDL levels or history suggest it.
Health information notice
General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.